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Neurobiology of Disease
The p38 MAPK Regulates Microglial Responsiveness to
Diffuse Traumatic Brain Injury
Adam D. Bachstetter,1 Rachel K. Rowe,2,3 Machi Kaneko,1 Danielle Goulding,1 Jonathan Lifshitz,4,5,6
and Linda J. Van Eldik1,2,3
1Sanders-Brown Center on Aging, 2Department of Anatomy and Neurobiology, and 3Spinal Cord and Brain Injury Research Center, University of Kentucky,
Lexington, Kentucky 40536, 4Barrow Neurological Institute at Phoenix Children’s Hospital, Phoenix, Arizona 85004, 5Department of Child Health,
University of Arizona College of Medicine, Phoenix, Arizona 85004, and 6Phoenix Veteran Affairs Healthcare System, Phoenix, Arizona 85004
Neuropathology after traumatic brain injury (TBI) is the result of both the immediate impact injury and secondary injury mechanisms.
Unresolved post-traumatic glial activation is a secondary injury mechanism that contributes to a chronic state of neuroinflammation in
both animal models of TBI and human head injury patients. We recently demonstrated, using in vitro models, that p38 MAPK signaling
in microglia is a key event in promoting cytokine production in response to diverse disease-relevant stressors and subsequent inflam-
matory neuronal dysfunction. From these findings, we hypothesized that the p38 signaling pathway in microglia could be contributing
to the secondary neuropathologic sequelae after a diffuse TBI. Mice where microglia were p38-deficient (p38 KO) were protected
against TBI-induced motor deficits and synaptic protein loss. In wild-type (WT) mice, diffuse TBI produced microglia morphological
activation that lasted for at least 7 d; however, p38 KO mice failed to activate this response. Unexpectedly, we found that the peak of the
early, acute phase cytokine and chemokine levels was increased in injured p38 KO mice compared with injured WT mice. The increased
cytokine levels in the p38 KO mice could not be accounted for by more infiltration of macrophages or neutrophils, or increased
astrogliosis. By 7 d after injury, the cytokine and chemokine levels remained elevated in injured WT mice but not in p38 KO mice.
Together, these data suggest that p38 balances the inflammatory response by acutely attenuating the early proinflammatory cytokine
surge while perpetuating the chronic microglia activation after TBI.
Introduction
Traumatic brain injury (TBI) represents a spectrum of patholog-
ical conditions, which range from focal to diffuse, and from mild
to severe (Saatman et al., 2008). Regardless of the cause of the
injury, fundamental to the survival of the organism is a repair
process that is remarkably conserved among different tissues and
in response to different injuries (Gurtner et al., 2008). Inflamma-
tion is central to the classical described repair process and, as
such, is critical for health of the organism. However, inflamma-
tion that is inefficient, excessive, or prolonged can result in infec-
tion, edema, or reactive oxygen species and produce collateral
damage, which persists after the primary injury. Therefore, un-
derstanding the role of inflammation in the multicellular repair
process after a brain injury is of great medical and biological
importance. The consequences of even a mild brain injury can be
long-lasting and increase the risk of dementia (Uryu et al., 2007;
Gavett et al., 2010; Johnson et al., 2012). Associated with the
secondary disease process after a TBI is persistent microglia acti-
vation lasting for more than a decade (Ramlackhansingh et al.,
2011; Giunta et al., 2012). Microglia, the resident CNS macro-
phage, respond within 30 min to a brain injury (Davalos et al.,
2005; Nimmerjahn et al., 2005). Once the microglia respond to
chemoattractants and damage-associated molecular patterns, the
microglia release inflammatory mediators (e.g., IL-1, TNF,
and nitric oxide). The inflammatory mediators and damage-
associated molecular patterns act on cytokine receptors and con-
served pattern recognition receptors (e.g., Toll-like receptors) to
initiate an acute phase response (Morganti-Kossmann et al.,
2007; Chen and Nunez, 2010). Phenotypic subpopulations of
activated microglia, based on a molecular signature of gene ex-
pression, are characterized as a classical proinflammatory state
(M1 microglia) or an alternatively activated state (M2 microglia)
associated with anti-inflammatory and wound healing functions
(Colton, 2009; David and Kroner, 2011).
Central to linking the inflammatory stimuli in microglia to
the cellular response is the mitogen-activated protein kinase
(MAPK) p38. The expression of p38 is ubiquitous; however,
recent studies have shown that p38 has unique functions de-
pending on cell, tissue, and disease stimulus. In experimental
autoimmune encephalomyelitis, p38 in dendritic cells, but not
T cells or macrophages, is necessary for the disease progression by
regulating a TH17 response (Huang et al., 2012). In microglia, p38
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has been shown to be important for phagocytosis of -amyloid
and axon debris (Reed-Geaghan et al., 2009; Hosmane et al.,
2012) as well as production of IL-1 and TNF (Bachstetter et al.,
2011). However, the role of p38 in the repair process after a
brain injury has not been defined. We used a diffuse brain injury
model without contusion, cavitation, or tissue destruction, but
with profound microglia activation (Cao et al., 2012). We report
here that p38 regulates the microglia morphological activation
and limits the acute phase cytokine response to the diffuse TBI.
Materials and Methods
Animals. The Institutional Animal Care and Use Committee of the Uni-
versity of Kentucky approved the use of animals in this study, which was
conducted in accordance with the principles of animal care and experi-
mentation in the Guide for the Care and Use of Laboratory Animals. To
generate p38 conditional knock-out mice, the first exon of the p38
gene (MAPK14 ) was flanked by two loxP sites and then crossed with mice
that contain Cre driven by the lysozyme promoter, as previously de-
scribed (Kang et al., 2008; Bachstetter et al., 2011; Xing et al., 2011). The
restricted cell-type expression of the lysozyme promoter (Clarke et al.,
1996; Clausen et al., 1999) results in cell-specific deletion of p38 MAPK
in myeloid cells, including microglia, as previously validated (Bachstetter
et al., 2011; Xing et al., 2011). The mice (all backcrossed to C57 Bl/6) were
maintained and bred as follows: p38 fl/fl wild-type and not carrying the
Cre allele (p38 WT) were bred with Lys-Cre hemizygotes. This gener-
ates litters where 50% of the mice are microglia/macrophage condi-
tional p38 KO and 50% are p38 fl/fl littermates (used as WT
controls). All experiments with p38 mice used both sexes of mice at
50:50 ratio. Genotyping was performed by Transnetyx. Male C57BL/6J
mice were obtained from The Jackson Laboratory.
Midline fluid percussion injury (mFPI). The animals were subjected to
mFPI as previously described (Lifshitz, 2008). Briefly, 3- to 4-month-old
male and female mice were used for the experiment. To prepare for the
mFPI, mice were anesthetized with 5% isoflurane before stabilizing the
head using ear bars in a stereotaxic frame (David Kopf Instruments).
Anesthesia was maintained with continuous inhalation of isoflurane
(3.5%, 1 L/min). A midline incision was made in the scalp to expose the
skull. A 3.0-mm-diameter craniotomy was made using a trephine along
the sagittal suture, midway between bregma and lambda. Mice were
excluded from the experiment if dura was breached during the craniot-
omy. The top portion of the Luer-Loc hub of a 20-gauge needle (BD
Biosciences) was cut away, beveled, scored, and affixed over the craniot-
omy site using cyanoacrylate. Dental acrylic was applied around the hub
to provide stability during the injury induction. After the dental acrylic
hardened, a Luer-Loc cap was applied to the hub and sutures were ap-
plied where necessary to close the skin around the dental acrylic head
stage. Mice were given 16 –24 h to recover from the craniotomy before
injury.
Before injury, mice were anesthetized for 5 min with 5% isoflurane in
a small induction chamber. Then, the Luer-loc cap was removed, and the
hub was filled with normal saline and attached to the male end of the fluid
percussion device, ensuring that no air bubbles were introduced into the
system. Once a normal breathing pattern resumed, before sensitivity to
stimulation, a pressure pulse was generated by the fluid percussion device
(Custom Design and Fabrication). An injury of moderate severity (1.2 
0.05 atm) was administered by releasing the pendulum onto the fluid
filled piston, moments before the reflexive responses returned. After in-
jury, the hub assembly was removed en bloc. The injury site was in-
spected, and the incision was sutured. The time to right was recorded.
The mice were placed in a cage with a warming pad and monitored until
normal movement and grooming resumed. Sham mice were subjected to
all the experimental and surgical conditions described above, except that
the fluid percussion injury was not administered.
Rotarod. Personnel blinded to animal groups measured the distance
mice traveled using the Rotor-Rod system from San Diego Instruments.
Animals were pretrained (60 s at 4 rpm for 3 trials) on the rotarod for two
consecutive days before the craniotomy. Testing began at 24 h after injury
and was repeated for the next 6 d. For the test, the animal was placed on
the rod with the starting speed set to 4 rpm, and the speed was then
continuously accelerated up to 25 rpm over 5 min. When the animal fell
off the rod breaking the photo beam, the instrument recorded latency to
fall and total distance traveled. Two trials were run daily for each animal,
and the mean of the two trials was plotted.
Death and brain tissue harvesting. Mice were killed by sodium pento-
barbital overdose and transcardially perfused with ice-cold PBS for 5
min. The brains were rapidly removed. On ice, the brain was bisected
along the sagittal plane with one hemisphere further dissected and flash
frozen in liquid nitrogen and stored at 80°C for subsequent biochem-
ical evaluation. The other hemisphere was immersion fixed in 4% para-
formaldehyde for 14 –16 h, before cryoprotection in a 30% sucrose/PBS
solution.
Biochemical endpoint analyses. For protein measurements, a PBS frac-
tion and a detergent fraction were generated from neocortical tissue
using a high shear homogenizer (Omni TH115). The PBS fraction was
prepared by homogenizing the cortical tissue in a 1:10 (weight/volume)
of ice-cold freshly prepared lysis buffer consisting of 1 g/ml Leupeptin,
1 mM PMSF, and 1 mM ethylenediaminetetraacetic acid. The cortical
homogenate was centrifuged at 12,000  g for 20 min at 4°C in a Beck-
man Microfuge 18, and supernatants collected for measurement of cyto-
kines. A detergent-solubilized fraction was prepared by resuspending
and rehomogenizing the pellet in a detergent-containing lysis buffer (tis-
sue protein extraction reagent with Halt protease and phosphatase inhib-
itor mixture; Thermo Scientific) at the same volume used for first
homogenization. Homogenates were cleared by centrifugation at
12,000  g for 20 min at 4°C, and supernatants were used for measure-
ment of synaptic proteins.
Cytokine levels were measured as previously described (Bachstetter et
al., 2011; Bachstetter et al., 2012) using Meso Scale Discovery (MSD)
custom multiplex high-sensitivity ELISA kits according to the manufac-
Figure 1. Myeloid-specific deletion of p38 protects mice from diffuse brain injury-induced
vestibulomotor impairments and synaptic protein loss. A, Injured WT mice (mFPI WT) demon-
strated significant impairments in rotarod performance compared with sham-injured mice and
mFPI p38 KO mice. The injured KO mice were not significantly different from the sham mice. B,
Although the differences did not reach statistical significance, at 7 d after injury, levels of the
synaptic proteins PSD95 and synaptophysin (SYP) were decreased in the WT mice compared
with sham, whereas the injury-induced decrease was not seen in the KO mice; n  8 –14 per
group. *p  0.05, sham versus mFPI WT. **p  0.01, sham versus mFPI WT. #p  0.05, mFPI
WT versus mFPI KO.
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turer’s instructions with minor modifications. Briefly, 25 l of the PBS
fraction supernatant was loaded per well of the MSD plate (100 g of
protein). The sample was incubated at 4°C for 14 h. All incubation
steps were done using an Eppendorf MixMate at 1000 rpm. Cytokine
levels were normalized to the total amount of protein in the sample
loaded as determined by BCA Protein Assay (Thermo Scientific).
Synaptic proteins levels were measured by immunoblots as previously
described (Bachstetter et al., 2012). Blots were probed using reagents and
manufacturer recommendations for Odyssey Infrared imaging system
(LI-COR Biosciences). The detergent-solubilized fraction (1 g) was
prepared in SDS buffer (LI-COR), separated on a 10% NuPAGE Novex
Bis-Tris Midi Gel (Invitrogen), and transferred to nitrocellulose mem-
brane using the iBlot system (Invitrogen). Blots were probed with the
following primary antibodies: rabbit anti-PSD95 (1:2000, Cell Signaling
Technology, catalog #3450); mouse anti-synaptophysin (clone SY38,
1:30,000, Millipore, catalog #MAB5258); rabbit anti-syntaxin 1 (1:
100,000, Millipore, catalog #ab5820), mouse anti-SNAP 25 (clone 20)
(1:10,000, BD Biosciences, catalog #610366). Rabbit anti-GAPDH (clone
14C10) (1:10,000, Cell Signaling Technology, catalog #2118) was used as
a loading control. The Odyssey Infrared imaging system (LI-COR Bio-
sciences) and integrated intensity values were used in statistics.
For gene expression, dissected neocortical tissues stored at 80°C were
used for RNA isolation using RNeasy mini-columns (QIAGEN, catalog
#74104) with on-column DNase treatment (QIAGEN, catalog #79254)
according to the manufacturer’s protocol. RNA quantity and quality
were determined using A260/A280 readings by NanoDrop (Thermo Sci-
entific). Reverse transcription (RT) was done following the manufactur-
er’s protocol using High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems, catalog #4368814). A no template and a no RT
control were conducted to control for contamination. Real-time PCR was
performed using the TaqMan Gene Expression assay kit (Applied Biosys-
tems, catalog #4444964) according to the manufacturer’s instructions on a
ViiA 7 Real-Time PCR System (Applied Biosystems). The following Taq-
Man probes (Applied Biosystems) were used: IL-1 (Mm00434228_m1),
IL-6(Mm00446190_m1),TNF(Mm00443258_m1),CCL2(Mm00441242_
m1), CCL3 (Mm00441258_m1), CD45 (Mm01293575_m1), CD68
(Mm00839636_g1), MHCII (Mm00439216_m1), arg1 (Mm00475988_
m1), YM1 (Mm00657889_mH), GLAST (Mm00600697_m1), GLT-1
(Mm00441457_m1), GFAP (Mm00546086_m1), S100B (Mm00485897_
m1), VIM (Mm01333430_m1), and 18S (Hs99999901_s1). Relative gene
expression was calculated by the 2CT method.
Immunohistochemistry (IHC). Using a sliding microtome with a freez-
ing stage, we collected serial coronal sections (30 m) of the hemi-brain
through the entire hemisphere and stored the sections in cryoprotectant
at 20°C. Staining procedures were conducted on free-floating sections
using every 12th section through the entire hemisphere. Primary and
secondary antibodies were diluted in 3% normal goat serum (LAMPIRE
Biological Laboratories, catalog #7332500) with 0.2% Triton X-100. En-
dogenous peroxidase activity was quenched with 3% H2O2 in methanol,
Figure 2. Changes in gene expression associated with glial activation after diffuse brain
injury. Temporal changes in cytokine/chemokine (A), microglia (B), and astrocyte markers (C)
were measured in the cortex of male C57BL/6J mice subjected to sham conditions (gray), or at
3 h (red), 9 h (green), 24 h (blue), or 7 d (black) after mFPI; n  3 per time point.
Figure 3. The increase in p-p38 after diffuse brain injury is associated with myeloid
cells. A, p-p38 IHC was seen in the WT mFPI mice at 6 h and 7 d post-injury (p.i.) but was
nearly absent in the sham-injured mice and the p38 KO mFPI mice. B, Quantification
shows a significant increase in the number of p-p38  cells in the injured WT mice at 6 h,
which persists to 7 d after injury. Injured p38 KO mice show little to no p-p38 immuno-
reactivity and are not different from sham-injured mice at either time point (n  6 –12
per group). *p  0.05. **p  0.01.
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before the tissue blocking in 10% normal goat
serum with 0.2% Triton X-100. Primary anti-
bodies used included the following: rabbit anti-
GFAP (1:10,000, Dako, catalog #Z0334); rabbit
anti-IBA1 (1:10,000, Wako, catalog #019-
19741); rat anti-CD45 (YW62.3) (1:10,000,
Thermo Scientific, catalog #MA1447081);
rat anti-CD68 (1:5000, Serotec catalog
#MCA1957T); rat anti-Ly6G/C (GR1) (1:800,
BD Biosciences PharMingen catalog #550291);
and rabbit anti-p-p38 (1:1000, Cell Signaling
Technology, catalog #9211). For the detection
of GFAP and IBA1, an HRP-conjugated goat
anti-rabbit IgG was used. For all other primary
antibodies, a biotinylated secondary antibody
was amplified in avidin-biotin substrate (ABC
kit, Vector Laboratories). All sections were de-
veloped in 0.5 mg/ml 3,3-diaminobenzidine
tetrahydrochloride solution (Sigma, catalog
#D5637). The tissue sections were dehydrated
through gradients of ethyl alcohol and finally
xylene. The sections were then coverslipped
with Permount Mounting Medium (Fisher
Scientific).
Quantitative image analysis of IHC. As previ-
ously described (Bachstetter et al., 2012), the
Aperio ScanScope XT digital slidescanner
was used to image the entire stained slide at
20 magnification to create a single high-
resolution digital image. The neocortex was
outlined using the Aperio ImageScope soft-
ware. The Aperio-positive pixel count algo-
rithm (version 9) was used to quantify the
amount of specific staining in the region.
The number of positive pixels was normal-
ized to the number of total pixels (positive
and negative) to account for variations in the
size of the region sampled. Color and inten-
sity thresholds were established to detect the
immunostaining as positive pixels and back-
ground staining as negative pixels. To quantify
the number of IBA1  clusters of microglia,
the Aperio nuclear algorithm (version 9). We operationally defined
microglia clusters as groups of cells where the processes of the cells
were overlapping, and with a total area covered by cells of 	1000 m.
To this end, a threshold was set in the nuclear algorithm, so only
clusters of microglia 	1000 m, regardless of curvature or round-
ness, would be quantified. We empirically found that these settings
would detect multicellular groups of microglia (	4) while not detect-
ing individual microglia. Once conditions were established for an
immunohistochemical stain, the entire batch of slides was analyzed
with the same parameters. The resulting color markup of the analysis
was confirmed for each slide. Because of the limited number of GR1 
and p-p38  cells, the Aperio ImageScope software was not used.
GR1  cells were manually counted in the cortex, and the number of
cells was then averaged by the number of sections. For p-p38 quanti-
fication, three or four randomly selected fields of the neocortex (1.5
to 2.5 mm bregma) were collected for each animal using a Nikon
Eclipse 90i upright microscope equipped with a Nikon DS-Ri1 digital
camera, and the number of positive cells were assessed using the
Nikon Elements BR software package, according to previously de-
scribed methods (Sudduth et al., 2012). Personnel blind to the exper-
imental conditions performed all quantifications.
Statistics. Statistical analysis was conducted using GraphPad prism
software, version 5 (GraphPad Software). Groups of two were compared
by unpaired t test. One-way ANOVA followed by Bonferroni’s multiple-
comparison test was used for comparisons among three or more groups,
unless otherwise indicated. Statistical significance was defined as p 
0.05. Values are expressed as mean  SEM.
Results
Myeloid-specific deletion of p38 reduces TBI-induced
motor deficits
We have previously reported using in vitro assays that microglia
p38 is critical for the production of proinflammatory cytokines
and microglia-mediated neuronal death (Xing et al., 2011); how-
ever, the relative in vivo contribution of microglia p38 to a brain
injury is unknown. To test the role of microglia p38 in vivo, we
used a model of diffuse TBI, which causes a traumatic axonal
injury throughout the mediodorsal neocortex, hippocampus,
and dorsolateral thalamus, without the formation of compres-
sion, contusion, or tissue loss (Kelley et al., 2006; Kelley et al.,
2007). There is leakage of the blood– brain barrier in the model
(Kelley et al., 2007), but the lack of a focal necrotic core allowed us
to address the role of microglia response to trauma with only a
limited influx of circulating adaptive and innate immune cells.
We compared the injury-induced responses in WT mice and in
p38 conditional KO mice where p38 is selectively deficient in
cells of the myeloid linage: neutrophils/macrophages/microglia
(p38 KO mice) (Kang et al., 2008; Bachstetter et al., 2011;
Hume, 2011; Xing et al., 2011).
To assess motor function, we used the rotarod task, which is
highly sensitive to vestibulomotor deficits associated with brain
injury (Hamm, 2001). Adult mice were trained for 2 d on the
Figure 4. p38 KO microglia fail to respond morphologically to a diffuse brain injury. A, IBA1 IHC shows a strong increase in
staining and morphological alterations in the WT mFPI mice post-injury (p.i.), which were absent in the KO mFPI mice 6 h after
injury and remained diminished in the KO mice 7 d after injury. Arrows indicate clusters of microglia around what appears to be a
blood vessel. B, Quantification shows a significant increase in IBA1 staining in the injured WT mice at 6 h, which persists to 7 d after
injury. Microglia in the KO mice demonstrated a failure to activate during the acute (6 h) or chronic phase (7 d) after the injury. C,
CD68 IHC further supports the lack of a microglia morphological response to the diffuse brain injury in the absence of p38, both
at acute time points and during the chronic phase after the injury. D, Quantification shows a significant increase in CD68 staining
in the WT-injured mice at 6 h that persisted to 7 d after injury, with minimal response in the KO mice. Data are presented as
percentage of sham; n  6 – 8 per group. *p  0.05. **p  0.01.
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rotarod task until all mice met the criterion of 1 min at 4 rpm.
From day 1 to day 7 after the diffuse brain injury, mice were tested
on an accelerating rotarod (0 –25 rpm over 5 min). As shown in
Figure 1A, injured WT mice showed a significant motor impair-
ment after injury compared with the uninjured sham mice,
whereas the p38 KO mice did not exhibit any significant motor
impairment after injury.
Synaptic protein levels in the cortex 7 d after injury were quan-
tified to determine whether the observed motor deficit was also
associated with synaptic loss. We found that there was a decrease
in PSD95 and synaptophysin protein levels after the diffuse brain
injury in the WT mice, although the decrease in protein levels did
not reach statistical significance as determined by a one-way
ANOVA (Fig. 1B). Interestingly, the injured microglia p38 KO
mice showed no decrease in synaptic protein levels and were
indistinguishable from sham controls (Fig. 1B).
Inflammatory cytokine and chemokine
response peaks during the first 9 h after
diffuse brain injury
To determine the temporal changes in the
inflammatory response after diffuse brain
injury, we subjected male C57BL/6J mice
to mFPI and then measured by real-time
PCR a panel of cytokine, chemokine, mi-
croglia, and astrocyte markers in the cor-
tex at select time points after the injury
(Fig. 2). Cytokines and chemokines were
found to peak between 3 h and 9 h after
the injury (Fig. 2A). Two markers associ-
ated with the alternative activation state
(M2) microglia phenotype, arg1 and
YM1, were found to be strongly increased
by 9 h; however, by 7 d, the expression of
the M2 markers was below the sham level
(Fig. 2B). The diffuse brain injury had a
limited effect on astrocyte markers, with
the exception of GFAP and vimentin
(VIM) (Fig. 2C).
Microglia continue to express p-p38
for at least 7 d after a diffuse
brain injury
Our previous work strongly implicates
p38 in the IL-1 and TNF response
from microglia evoked by inflammatory
stimuli (Bachstetter et al., 2011). As the
peak cytokine response was found to oc-
cur between 3 to 9 h after the diffuse brain
injury, we predicted that, at 6 h after the
injury, we would see elevated p-p38 in
the injured brain. Figure 3A shows the re-
sult of p-p38 IHC in mice 6 h and 7 d after
the mFPI. In the WT mFPI mice, p-p38
cells were found throughout the injured
cortex at 6 h, with a similar number of
p-p38 cells found at 7 d after the diffuse
TBI. In contrast, p-p38 cells were nearly
absent in the p38 KO mFPI mice (Fig.
3B). IHC for p-p38 is not specific for cell
type or p38 isotype. However, the obser-
vation that the p38 KO mice show essen-
tially no p-p38 staining further validates
the KO and provides support that, after a
diffuse TBI, it is myeloid cells, presumably
microglia, and the  isoform of p38 that is responsible for the
p-p38 increase seen after injury.
Microglia activation in response to a diffuse TBI is dependent
on p38 MAPK
Microglia, the resident tissue immune effector cells of the CNS,
rapidly respond to tissue trauma by altering their morphology
and moving to the site of injury (Davalos et al., 2005). The intracel-
lular signal transduction that regulates this response is not fully
known. We have previously reported in rats that the mFPI model
induces a classical activation of microglia using IBA1 (Cao et al.,
2012). This activation of microglia after mFPI without tissue loss
provided us with the opportunity to probe the intracellular pathways
involved in the microglia morphological response using an in vivo
disease relevant injury model. Figure 4A shows the result of IBA1
Figure 5. Microglia clustering is dependent on p38 KO after a diffuse TBI. A–D, IBA1 IHC shows the spectrum of microglia
activation seen in the WT mice 6 h after the diffuse brain injury. Note the long, rod-shaped microglia (A), trains of multiple microglia
in plane with the axonal columns in the cortex (B), and multiple microglia in the shape of a layer-V pyramidal cell (C), as well as
IBA1  cells with retracted processes with large swellings (D). In contrast, the p38 KO mice exhibited thin ramified microglia
processes (E) or looked morphologically similar (F ) to sham-injured mice (G). A cluster of microglia from a WT mFPI mouse shows
the IBA1 staining (H ), and the Aperio nuclear algorithm generated markup shows the reliable detection of the microglia clusters
(demonstrated here as the black markup) and not individual cells (arrows) (I ). Quantification shows a significant increase in IBA1
clusters in the WT-injured mice at 6 h after injury (J ). Data are presented as percentage of sham; n  6 – 8 per group. *p  0.05.
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IHC in mice 6 h and 7 d after the mFPI. In the sham-injured mice, a
uniform spatial distribution of the IBA1 microglia, characteristic
of quiescent phenotype, was seen in the sham mice at both time
points. After the brain injury in WT mice, there was a strong mor-
phological activation of the IBA1 cells, including large multicellu-
lar groups, or clusters, of microglia. Quantification of the intensity of
the IBA1 immunoreactivity throughout the neocortex demon-
strated a significant increase in IBA1 staining in the injured WT mice
compared with the injured p38 KO mice (Fig. 4B). IHC for CD68,
a macrophage marker associated with phagocytic cells (da Silva and
Gordon, 1999; Kurushima et al., 2000), also clearly showed an up-
regulation at 6 h and 7 d after injury in WT mice (Fig. 4C). In
contrast, the p38 KO mice failed to show increased CD68 stain-
ing after the injury (Fig. 4D).
As shown in Figure 5, by 6 h after injury in the WT mice, a
strong increase in the IBA1 immunoreactivity was found, the
uniform microglia distribution was lost, and the cells formed
clusters where the individual cell processes become indistin-
guishable by light microscopy. In some instances, the mor-
phology of the microglia took on a rod shape perpendicular to
the cortex (Fig. 5 A, B) (Cao et al., 2012; Ziebell et al., 2012). At
times, the clusters of microglia appeared to take on the shape
of a layer-V pyramidal neuron (Fig. 5C). Microglia in the WT
mice at 6 h after injury were also found to have processes with
large swellings (Fig. 5D). In the p38 KO mice, at 6 h after
injury, these unusual microglia morphologies were not ob-
served (Fig. 5 E, F ). Instead, microglia in the injured p38 KO
mice were found to have thin highly ramified processes similar
to the sham mice (Fig. 5G), and in stark contrast to the injured
WT mice. Using the Aperio nuclear algorithm, we quantified
the number of microglia clusters 6 h after injury and found
that the p38 was necessary for the microglia to form multi-
cellular clusters (Fig. 5H–J ).
Suppression of the acute proinflammatory response after a
diffuse TBI requires p38 in myeloid cells
Previously, we have found, in a diffuse TBI model, that a surge of
proinflammatory cytokines occurs within the first 12 h, which is
important for subsequent cognitive impairments (Lloyd et al.,
2008). Using in vitro assays, we have also reported that p38 is a
key intracellular signaling kinase in microglia involved in the
production of proinflammatory cytokines (Bachstetter et al.,
2011). Therefore, we hypothesized that microglia p38 is critical
for the cytokine surge after a diffuse brain injury. However, un-
expectedly and contrary to our hypothesis, we found elevated
levels of the proinflammatory cytokines IL-1, IL-6, and TNF
(Fig. 6A) and the chemokines CCL2, CCL5, and CXCL1 (Fig. 6B)
Figure 6. Cytokine and chemokine levels are acutely enhanced in the p38 KO mice after a
diffuse brain injury. The protein levels of a panel of inflammatory cytokines (A) and chemokines
(B) were measured in the neocortex by MSD multiplex immunoassay. The injured p38 KO mice
were found to have significantly enhanced cytokine response at 6 h; but by 7 d after injury, the
cytokine response in the KO mice was below (IL-1) or equal to (IL-6) the response of the
WT-injured mice. The chemokines were also significantly increased at 6 h in the p38 KO
mice; and by 7 d, the levels were near baseline; n  6 –12 per group. *p  0.05. **p 
0.01. ***p  0.001. N.D., Not detected.
Figure 7. Enhanced cytokine and chemokine gene expression is seen in the p38 KO mice at
6 h after diffuse brain injury. Temporal changes in cytokine/chemokine (A), microglia (B), and
astrocyte markers (C) were measured from the cortex harvested from sham mice (gray repre-
sents 6 h; black, 7 d), injured WT mice (red, 6 h; purple, 7 d), or injured p38 KO mice (blue, 6 h;
green, 7 d); n  4 –10 per group. **p  0.01, sham versus mFPI WT. #p  0.05, mFPI WT
versus mFPI KO. ##p  0.01, mFPI WT versus mFPI KO. ‡p  0.05, sham versus mFPI KO. ‡‡p 
0.01, sham versus mFPI KO.
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in the cortex of p38 KO mice 6 h after the injury compared with
the sham-injured and WT mFPI mice. Interestingly, by 7 d after
the injury, the levels of IL-1 remained significantly elevated in
the WT mFPI mice but were back to basal in the p38 KO mFPI
mice (Fig. 6A). The levels of the other cytokines and chemokines
were also low to undetected by 7 d after injury in WT and p38
KO mice.
Gene expression changes reveal increased M1
cytokine/chemokine and heightened M2 response in the p38
KO mice at 6 h after injury
To begin to explore the mechanism by which the acute proin-
flammatory response is increased in the KO mice, we measured a
panel of cytokine, chemokine, microglia, and astrocyte markers
by real-time PCR. As shown in Figure 7A, a significant increase
was seen in the expression of proinflammatory cytokines IL-1,
TNF, and the chemokines CCL2 and CCL3 in the cortex of
p38 KO mice 6 h after the injury compared with the injured WT
and sham-injured mice, replicating the changes in cytokines and
chemokines seen at the protein level. By 7 d after the injury, the
levels of IL-1 expression in the KO mice were found to be sig-
nificantly less than that of the WT mice (Fig. 7A). Interestingly,
we also found that, at 6 h after the injury, KO mice had a more
robust M2 response, as shown by elevated expression of the M2
markers arg1 and YM1, although the increase did reach statistical
significance as determined by a one-way ANOVA (Fig. 7B).
Whether these effects are solely from microglia remains to be
shown. Few changes were seen in the expression of astrocyte
markers after the diffuse brain injury at either time point. How-
ever, we did find that, at 6 h after the injury, the expression of
GFAP and VIM was significantly increased in the KO mice com-
pared with the WT mice (Fig. 7C).
Astrogliosis remains intact in p38 KO mice after a
diffuse TBI
As we found increased expression of GFAP and VIM in the p38
KO mice, we sought to determine whether there might be an
increasing astrogliosis that may account for the acute increase in
cytokines seen in the p38 KO mice. Therefore, we performed
IHC for GFAP, a marker of astrocytes, which in the mouse is
normally found expressed at low levels in the cortex. As shown in
Figure 8, in the sham-injured mice, very little GFAP staining was
seen in the cortex. The diffuse TBI caused a strong astrogliosis,
which was most evident at 7 d after injury when injured mice
showed a robust increase in GFAP staining regardless of genotype
(Fig. 8A). Quantification of staining in the cortex demonstrated
that the p38 KO mice had significantly less GFAP staining at 6 h
after injury compared with the injured WT mice. By 7 d after
injury, there was no detectable difference in GFAP staining be-
tween the injured WT or p38 KO mice (Fig. 8A,B).
The number of infiltrating innate immune cells do not
account for the increase in cytokines seen in the KO mice
after a diffuse TBI
CD45 is a transmembrane protein tyrosine phosphatase that is
expressed on all nucleated hematopoietic cells (Penninger et al.,
2001). The expression of CD45 on resident microglia is low; but
upon stimulation, the expression of CD45 on microglia is up-
regulated (Sedgwick et al., 1991), and high expression of CD45 as
determined by flow cytometry is associated with infiltrating mac-
rophages (Mizutani et al., 2012). Figure 9A shows representative
photomicrographs of the CD45 IHC. A significant increase in
CD45 staining was seen in the cortex of injured WT mice, but a
much more limited increase in CD45 staining in the p38 KO
mice (Fig. 9B).
Previous studies have suggested that macrophages are neces-
sary to limit the number of neutrophils after trauma (Lucas et al.,
2010), by regulating neutrophil recruitment and clearance
(Soehnlein and Lindbom, 2010). As a myeloid cell, neutrophils
would also be deficient in p38 in the KO mouse model; there-
fore, we quantified the number of GR1 cells in the cortex to
determine whether there was an increase in the number of neu-
trophils. We found a significant increase (p  0.05) in the num-
ber of GR1 cells in the cortex after diffuse brain injury in WT
mice; however, there was no difference between the injured WT
or p38 KO mice in the number of GR1 cells (Fig. 9C). This
suggests that neutrophil recruitment after the diffuse brain injury
is independent of p38, as we do not see a difference in the
number of GR1 cells. In contrast, the activation and/or recruit-
ment of macrophage/microglia after the diffuse brain injury is
p38-dependent, as there is less CD45 staining in the KO mice.
Our data clearly show that the numbers of CD45 cells and
GR1 cells are either decreased or the same in the p38 KO mice;
therefore, an increased number of infiltrating immune cells is not
the mechanism for the increase in cytokines seen in the KO mice.
However, it should be noted that determining the number of
CD45 cells and GR1 cells alone does not rule out the possibil-
ity that the activation state and/or ratio of the infiltrating mono-
Figure 8. There is intact astrogliosis in myeloid-deficient p38 KO mice after injury. A, GFAP
IHC shows a strong increase in staining and morphological alterations in the WT mFPI mice 6 h
after injury, which was not as prominent in the p38 KO mFPI mice. By 7 d after injury, WT and
KO mice showed similar GFAP staining. B, Quantification shows a significant increase in GFAP at
6 h after injury in WT mice but not KO mice. At 7 d, there was no difference in astrogliosis
between the WT and KO injured mice. Data are presented as percentage of sham (n  6 –12 per
group). *p  0.05. **p  0.01. ##p  0.01, sham versus mFPI KO (t test).
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cytes/macrophages versus brain-resident microglia may differ in
the p38 WT or KO mice and that there may be qualitative differ-
ences in the responsiveness caused by the lack of p38 in the cells
that do infiltrate.
Discussion
In the present study, we have identified p38 as a critical component
in the intracellular signaling mechanisms by which a diffuse brain
injury leads to activation of microglia. Moreover, we found that
p38 has an important role in perpetuating injury-induced micro-
glia activation, despite the fact that acutely p38 suppresses the peak
cytokine response to diffuse brain injury. We propose a model (Fig.
10) where the hypertrophy and directional chemotaxis of microglia
after a brain injury are dependent on p38. In the absence of p38,
there is a failure of microglia priming such that the enhanced level of
cytokines seen in the p38 KO mice does not produce microglia
activation or chronically elevated cytokines. Therefore, microglia
priming by p38 is important to preserve a state of chronic neuro-
inflammation after a diffuse brain injury; inhibition or elimination
of p38 can improve outcome.
Microglia are known to respond rapidly (30 min) and migrate
to the source of injury (Davalos et al., 2005; Nimmerjahn et al.,
2005). The signal transduction mechanisms in microglia that lead
to this response are poorly understood, yet there is strong support
for the involvement of p38 in chemotaxis (Heit et al., 2002, 2008),
with chemoattractant selectivity (i.e., complement C5a) not be-
ing p38-dependent (Isfort et al., 2011), whereas IL-1 is p38-
dependent (Ferreira et al., 2012). Dead, dying, and injured cells
release “find me” and “eat me” signals that attract microglia and
macrophages to isolate the damage and remove the dead cells
(Ravichandran, 2011). Purinergic signaling is the most well-
described chemoattractant in the CNS (Davalos et al., 2005;
Nimmerjahn et al., 2005; Haynes et al., 2006). ATP has been
shown to increase levels of phospho-p38 in microglia (Trang et
al., 2009). However, the role of p38 in chemotaxis to ATP is not
clear, as chemotaxis to ATP has been reported to be both depen-
dent (Heit et al., 2008) and independent of p38 (Isfort et al.,
2011). This may be the result of differences in chemoattractant
signals that activate microglia distally (chemokines) versus che-
moattractant signals at the end target and most likely involves an
integration of these signals. In complex gradients of chemoattrac-
tants, p38 and PI3K can have opposing roles in the distal versus
end target movement, with p38 important for movement toward
end target (Heit et al., 2008). Our data suggest that p38 may
participate in the integration of the chemoattractant signals after
the injury. At 6 h after the diffuse brain injury, we found a striking
activation of microglia, with a loss of the normal spatial distribu-
tion, clustering of multiple cells around presumably injured neu-
rons and blood vessels, and the appearance of processes with
swollen inclusions. In injured mice where p38 is deficient in
microglia, we found only a limited increase in microglia reactiv-
ity, at both 6 h and 7 d after the injury, and failure of microglia to
form multicellular clusters. We also found very limited CD45
staining in the injured p38 KO mice, which could represent a
decreased level of macrophage infiltration.
Figure 9. Myeloid-deficient p38 KO mice have a limited increase in CD45, but similar changes in GR1  monocytes/neutrophils, compared with WT mice. A, Representative photomicrographs
of CD45  IHC in the cortex 6 h post-injury (p.i.). B, A significant increase in CD45  staining was found in the cortex of WT mFPI mice compared with sham-injured mice, whereas p38 KO mice
showed very little increase in CD45  staining. C, The number of GR1  cells were counted in the cortex and presented as the average number of GR1  cells per coronal tissue section. WT and KO
mice showed similar numbers of GR1  cells after injury (n  6 –12 per group). *p  0.05. **p  0.01. ***p  0.001.
Figure 10. Proposed model of the role of p38 in the microglia response to diffuse brain
injury. A, In WT mice, a mild to moderate diffuse brain injury induces a reactive glia response
associated with elevated inflammatory cytokines and chemokines, morphological hypertrophy,
and loss of microglia spatial domains as early as 6 h after injury. The reactive glia response,
which is exemplified by an “M1” proinflammatory phenotype, persists for at least 7 d after the
injury. B, In the p38 KO mice, the acute phase cytokine response is elevated compared with
the WT mice. However, despite the higher cytokine response, there is a failure of the microglia
deficient in p38 to exhibit an acute or chronic phase morphological activation response. C, Our
results suggest that p38 is a critical kinase in the detrimental inflammatory feedforward loop
responsible for neuromotor deficits.
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Microglia are known to phagocytose dying cells (Katayama et
al., 2012), myelin and axonal debris (Tanaka et al., 2009;
Ghasemlou et al., 2010), misfolded proteins (Reed-Geaghan et
al., 2009), and synapses in response to injury such as ischemia
(Wake et al., 2009), or as an activity-dependent synaptic pruning
process (Schafer et al., 2012). In many instances, this process has
been shown to be p38-dependent (Reed-Geaghan et al., 2009;
Tanaka et al., 2009; Ghasemlou et al., 2010; Katayama et al.,
2012). Therefore, the failure of microglia to activate and form
multicellular clusters may reflect failure to activate a p38-
dependent phagocytosis response, which is supported by the di-
minished CD68 response seen in the injured p38 KO mice.
In the diffuse brain injury model in this study, previous re-
ports demonstrate axonal injury, but lack of neuronal death.
Moreover, the injured neurons in this model show signs of axonal
regeneration and recovery with the peak of the neuron injury
response occurring during the first 7 d and partial recovery over
the subsequent month (Singleton et al., 2002; Greer et al., 2011;
Greer et al., 2012), suggesting that, although these neurons are
endangered, they are salvageable. Our data suggest that limiting
the microglia response to the injury is potentially beneficial, as
shown by the lack of motor impairments in the p38 KO mice.
The clearance of axonal debris, which in vitro is p38-dependent, is
beneficial for the promotion of axonal growth (Hosmane et al.,
2012). However, if the axon was damaged, but not beyond repair,
clearance of this axon would be detrimental. Therefore, regulat-
ing the microglia response and/or p38 signaling in a mild brain
injury may produce a significantly different outcome than in a
TBI with pronounced neuronal death or blood– brain barrier
damage.
Evidence from clinical studies and preclinical animal models
suggest the key role of proinflammatory cytokine overproduction
from activated glia as a potential driving force for pathology pro-
gression in TBI (Schmidt et al., 2005; Kelley et al., 2006; Lloyd et
al., 2008; Cao et al., 2012). One of the most striking findings of
our study was the demonstration that the inflammatory cytokine
response in the CNS, which dogmatically has been associated
with the activation of microglia, can be clearly disconnected from
the microglia activation via a p38-dependent mechanism after a
diffuse brain injury. The seemingly divergent reaction to the dif-
fuse brain injury (i.e., a robust increase in acute cytokine response
with a lack of microglia activation in the p38 conditional KO
mice) distinctly shows that microglia activation, as determined
morphologically, does not necessitate the production of cyto-
kines, and vice versa. Nevertheless, our data suggest that, if mi-
croglia are incapable of responding to the acute phase cytokine
response, because of a lack of p38, then the increase in cytokines
does not lead to chronic or enhanced neuroinflammation and
subsequent synaptic and behavioral impairments.
Although p38 is undoubtedly important in the production
of proinflammatory cytokines (Bachstetter et al., 2011), it is be-
coming apparent that p38 also activates negative feedback path-
ways that limit the production of proinflammatory cytokines (for
review, see Bachstetter and Van Eldik, 2010). The evolutionary
importance of a tightly regulated immune response is exempli-
fied by the numerous known ways and potential yet undiscovered
ways that the inflammatory response is self-limiting. It has pre-
viously been demonstrated in a variety of cell types that p38 can
antagonize JNK, ERK, and NFB signaling (Zhang et al., 2001;
Mathur et al., 2004; Gorska et al., 2007; Heinrichsdorff et al.,
2008; Kim et al., 2008). One well-described mechanism of nega-
tive feedback is the dual-specificity protein phosphatase 1, which
dephosphorylates both phosphothreonine and phosphotyrosine
residues to inactivate p38 and JNK (Liu et al., 2007). The expres-
sion of dual-specificity protein phosphatase 1 is induced by p38
and ERK via a CREB-binding site in the promoter of dual-
specificity protein phosphatase 1 (Sommer et al., 2000). In addi-
tion, p38 has been shown to block the phosphorylation of ERK
by a direct interaction (Zhang et al., 2001). Therefore, the in-
crease in proinflammatory cytokines we see at 6 h in the p38 KO
mice could be a result of prolonged JNK activation; more work is
necessary to test this hypothesis.
Previous studies report increased levels of p38 after TBI and
spinal cord injury (SCI) (Mori et al., 2002; Xu et al., 2006; Stirling
et al., 2008; Ghasemlou et al., 2010) However, preclinical exper-
iments using small-molecule p38 inhibitors have demonstrated
mixed results, with a lack of neuroprotection after a focal TBI
(Mori et al., 2002), or moderate SCI (Stirling et al., 2008), while
showing protection in a mild SCI (Xu et al., 2006). A recent study
using mice deficient in MK2, a direct downstream substrate of
p38, demonstrated reduced inflammation and improved loco-
motor recovery after SCI (Ghasemlou et al., 2010). These results
are in agreement with our current study, which implicates p38 as
important for regulating inflammation as part of the repair pro-
cess to injury. However, inflammation is also critical to the repair
process; and depending on the type and severity of the injury,
inhibiting the p38-MK2 pathway can slow wound healing
(Thuraisingam et al., 2010). Nevertheless, in a sterile environ-
ment, such as the CNS, suppressing the secondary injury re-
sponse leading to the chronic inflammatory sequelae via the p38
pathway can be neuroprotective as demonstrated in preclinical
models of ischemia (Barone et al., 2001; Legos et al., 2001; Wang
et al., 2002), Alzheimer’s disease (Culbert et al., 2006; Munoz et
al., 2007), and Parkinson’s disease (Thomas et al., 2008). Al-
though the p38 pathway appears to be a promising clinical target
for the treatment of CNS disorders with dysregulated neuroin-
flammatory responses, more studies are still necessary to deter-
mine therapeutic window, dosing, and long-term efficacy and
to improve the pharmacodynamics and selectivity of small-
molecule p38 inhibitors. In summation, our study demonstrates
that p38 is a critical intracellular signaling molecule in microglia
regulation of the inflammatory repair process after a diffuse TBI.
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Chen GY, Nuñez G (2010) Sterile inflammation: sensing and reacting to
damage. Nat Rev Immunol 10:826 – 837. CrossRef Medline
Bachstetter et al. • Microglia p38 in TBI J. Neurosci., April 3, 2013 • 33(14):6143– 6153 • 6151
Clarke S, Greaves DR, Chung LP, Tree P, Gordon S (1996) The human
lysozyme promoter directs reporter gene expression to activated myelo-
monocytic cells in transgenic mice. Proc Natl Acad Sci U S A 93:1434 –
1438. CrossRef Medline
Clausen BE, Burkhardt C, Reith W, Renkawitz R, Förster I (1999) Condi-
tional gene targeting in macrophages and granulocytes using LysMcre
mice. Transgenic Res 8:265–277. CrossRef Medline
Colton CA (2009) Heterogeneity of microglial activation in the innate im-
mune response in the brain. J Neuroimmune Pharmacol 4:399 – 418.
CrossRef Medline
Culbert AA, Skaper SD, Howlett DR, Evans NA, Facci L, Soden PE, Sey-
mour ZM, Guillot F, Gaestel M, Richardson JC (2006) MAPK-
activated protein kinase 2 deficiency in microglia inhibits pro-
inflammatory mediator release and resultant neurotoxicity: relevance
to neuroinflammation in a transgenic mouse model of Alzheimer dis-
ease. J Biol Chem 281:23658 –23667. CrossRef Medline
da Silva RP, Gordon S (1999) Phagocytosis stimulates alternative glycosyla-
tion of macrosialin (mouse CD68), a macrophage-specific endosomal
protein. Biochem J 338:687– 694. CrossRef Medline
Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin
ML, Gan WB (2005) ATP mediates rapid microglial response to local
brain injury in vivo. Nat Neurosci 8:752–758. CrossRef Medline
David S, Kroner A (2011) Repertoire of microglial and macrophage re-
sponses after spinal cord injury. Nat Rev Neurosci 12:388 –399. CrossRef
Medline
Ferreira R, Santos T, Cortes L, Cochaud S, Agasse F, Silva AP, Xapelli S, Malva
JO (2012) Neuropeptide Y inhibits interleukin-1 -induced microglia
motility. J Neurochem 120:93–105. CrossRef Medline
Gavett BE, Stern RA, Cantu RC, Nowinski CJ, McKee AC (2010) Mild trau-
matic brain injury: a risk factor for neurodegeneration. Alzheimers Res
Ther 2:18. CrossRef Medline
Ghasemlou N, Lopez-Vales R, Lachance C, Thuraisingam T, Gaestel M, Rad-
zioch D, David S (2010) Mitogen-activated protein kinase-activated
protein kinase 2 (MK2) contributes to secondary damage after spinal cord
injury. J Neurosci 30:13750 –13759. CrossRef Medline
Giunta B, Obregon D, Velisetty R, Sanberg PR, Borlongan CV, Tan J (2012)
The immunology of traumatic brain injury: a prime target for Alzheimer’s
disease prevention. J Neuroinflammation 9:185. CrossRef Medline
Gorska MM, Liang Q, Stafford SJ, Goplen N, Dharajiya N, Guo L, Sur S,
Gaestel M, Alam R (2007) MK2 controls the level of negative feedback in
the NF-B pathway and is essential for vascular permeability and airway
inflammation. J Exp Med 204:1637–1652. CrossRef Medline
Greer JE, McGinn MJ, Povlishock JT (2011) Diffuse traumatic axonal injury
in the mouse induces atrophy, c-Jun activation, and axonal outgrowth in
the axotomized neuronal population. J Neurosci 31:5089 –5105. CrossRef
Medline
Greer JE, Povlishock JT, Jacobs KM (2012) Electrophysiological abnormal-
ities in both axotomized and nonaxotomized pyramidal neurons follow-
ing mild traumatic brain injury. J Neurosci 32:6682– 6687. CrossRef
Medline
Gurtner GC, Werner S, Barrandon Y, Longaker MT (2008) Wound repair
and regeneration. Nature 453:314 –321. CrossRef Medline
Hamm RJ (2001) Neurobehavioral assessment of outcome following trau-
matic brain injury in rats: an evaluation of selected measures. J Neu-
rotrauma 18:1207–1216. CrossRef Medline
Haynes SE, Hollopeter G, Yang G, Kurpius D, Dailey ME, Gan WB, Julius D
(2006) The P2Y(12) receptor regulates microglial activation by extracel-
lular nucleotides. Nat Neurosci 9:1512–1519. CrossRef Medline
Heinrichsdorff J, Luedde T, Perdiguero E, Nebreda AR, Pasparakis M (2008)
p38  MAPK inhibits JNK activation and collaborates with IB kinase 2 to
prevent endotoxin-induced liver failure. EMBO Rep 9:1048 –1054.
CrossRef Medline
Heit B, Tavener S, Raharjo E, Kubes P (2002) An intracellular signaling
hierarchy determines direction of migration in opposing chemotactic
gradients. J Cell Biol 159:91–102. CrossRef Medline
Heit B, Robbins SM, Downey CM, Guan Z, Colarusso P, Miller BJ, Jirik FR,
Kubes P (2008) PTEN functions to ‘prioritize’ chemotactic cues and
prevent ‘distraction’ in migrating neutrophils. Nat Immunol 9:743–752.
CrossRef Medline
Hosmane S, Tegenge MA, Rajbhandari L, Uapinyoying P, Kumar NG, Thakor
N, Venkatesan A (2012) Toll/interleukin-1 receptor domain-containing
adapter inducing interferon- mediates microglial phagocytosis of de-
generating axons. J Neurosci 32:7745–7757. CrossRef Medline
Huang G, Wang Y, Vogel P, Kanneganti TD, Otsu K, Chi H (2012) Signaling
via the kinase p38alpha programs dendritic cells to drive TH17 differen-
tiation and autoimmune inflammation. Nat Immunol 13:152–161.
CrossRef Medline
Hume DA (2011) Applications of myeloid-specific promoters in transgenic
mice support in vivo imaging and functional genomics but do not support
the concept of distinct macrophage and dendritic cell lineages or roles in
immunity. J Leukoc Biol 89:525–538. CrossRef Medline
Isfort K, Ebert F, Bornhorst J, Sargin S, Kardakaris R, Pasparakis M, Bähler M,
Schwerdtle T, Schwab A, Hanley PJ (2011) Real-time imaging reveals
that P2Y2 and P2Y12 receptor agonists are not chemoattractants and
macrophage chemotaxis to complement C5a is phosphatidylinositol
3-kinase (PI3K)- and p38 mitogen-activated protein kinase (MAPK)-
independent. J Biol Chem 286:44776 – 44787. CrossRef Medline
Johnson VE, Stewart W, Smith DH (2012) Widespread  and amyloid-
pathology many years after a single traumatic brain injury in humans.
Brain Pathol 22:142–149. CrossRef Medline
Kang YJ, Chen J, Otsuka M, Mols J, Ren S, Wang Y, Han J (2008) Macro-
phage deletion of p38 partially impairs lipopolysaccharide-induced cel-
lular activation. J Immunol 180:5075–5082. Medline
Katayama T, Kobayashi H, Okamura T, Yamasaki-Katayama Y, Kibayashi T,
Kimura H, Ohsawa K, Kohsaka S, Minami M (2012) Accumulating mi-
croglia phagocytose injured neurons in hippocampal slice cultures: in-
volvement of p38 MAP kinase. PLoS One 7:e40813. CrossRef Medline
Kelley BJ, Farkas O, Lifshitz J, Povlishock JT (2006) Traumatic axonal injury
in the perisomatic domain triggers ultrarapid secondary axotomy and
Wallerian degeneration. Exp Neurol 198:350 –360. CrossRef Medline
Kelley BJ, Lifshitz J, Povlishock JT (2007) Neuroinflammatory responses
after experimental diffuse traumatic brain injury. J Neuropathol Exp
Neurol 66:989 –1001. CrossRef Medline
Kim C, Sano Y, Todorova K, Carlson BA, Arpa L, Celada A, Lawrence T, Otsu
K, Brissette JL, Arthur JS, Park JM (2008) The kinase p38  serves cell
type-specific inflammatory functions in skin injury and coordinates pro-
and anti-inflammatory gene expression. Nat Immunol 9:1019 –1027.
CrossRef Medline
Kurushima H, Ramprasad M, Kondratenko N, Foster DM, Quehenberger O,
Steinberg D (2000) Surface expression and rapid internalization of mac-
rosialin (mouse CD68) on elicited mouse peritoneal macrophages. J Leu-
koc Biol 67:104 –108. Medline
Legos JJ, Erhardt JA, White RF, Lenhard SC, Chandra S, Parsons AA, Tuma
RF, Barone FC (2001) SB 239063, a novel p38 inhibitor, attenuates early
neuronal injury following ischemia. Brain Res 892:70 –77. CrossRef
Medline
Lifshitz J (2008) Fluid percussion injury. In: Animal models of acute neuro-
logical injuries (Chen J, ed), pp 369 –384. Totowa, NJ: Humana.
Liu Y, Shepherd EG, Nelin LD (2007) MAPK phosphatases: regulating the
immune response. Nat Rev Immunol 7:202–212. CrossRef Medline
Lloyd E, Somera-Molina K, Van Eldik LJ, Watterson DM, Wainwright MS
(2008) Suppression of acute proinflammatory cytokine and chemokine
upregulation by post-injury administration of a novel small-molecule
improves long-term neurologic outcome in a mouse model of traumatic
brain injury. J Neuroinflammation 5:28. CrossRef Medline
Lucas T, Waisman A, Ranjan R, Roes J, Krieg T, Müller W, Roers A, Eming SA
(2010) Differential roles of macrophages in diverse phases of skin repair.
J Immunol 184:3964 –3977. CrossRef Medline
Mathur RK, Awasthi A, Wadhone P, Ramanamurthy B, Saha B (2004) Re-
ciprocal CD40 signals through p38MAPK and ERK-1/2 induce counter-
acting immune responses. Nat Med 10:540 –544. CrossRef Medline
Mizutani M, Pino PA, Saederup N, Charo IF, Ransohoff RM, Cardona AE
(2012) The fractalkine receptor but not CCR2 is present on microglia
from embryonic development throughout adulthood. J Immunol 188:
29 –36. CrossRef Medline
Morganti-Kossmann MC, Satgunaseelan L, Bye N, Kossmann T (2007)
Modulation of immune response by head injury. Injury 38:1392–1400.
CrossRef Medline
Mori T, Wang X, Jung JC, Sumii T, Singhal AB, Fini ME, Dixon CE, Alessan-
drini A, Lo EH (2002) Mitogen-activated protein kinase inhibition in
traumatic brain injury: in vitro and in vivo effects. J Cereb Blood Flow
Metab 22:444 – 452. CrossRef Medline
Munoz L, Ralay Ranaivo H, Roy SM, Hu W, Craft JM, McNamara LK, Chico
6152 • J. Neurosci., April 3, 2013 • 33(14):6143– 6153 Bachstetter et al. • Microglia p38 in TBI
LW, Van Eldik LJ, Watterson DM (2007) A novel p38  MAPK inhibitor
suppresses brain proinflammatory cytokine up-regulation and attenuates
synaptic dysfunction and behavioral deficits in an Alzheimer’s disease
mouse model. J Neuroinflammation 4:21. CrossRef Medline
Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are
highly dynamic surveillants of brain parenchyma in vivo. Science 308:
1314 –1318. CrossRef Medline
Penninger JM, Irie-Sasaki J, Sasaki T, Oliveira-dos-Santos AJ (2001) CD45:
new jobs for an old acquaintance. Nat Immunol 2:389 –396. CrossRef
Medline
Ramlackhansingh AF, Brooks DJ, Greenwood RJ, Bose SK, Turkheimer FE,
Kinnunen KM, Gentleman S, Heckemann RA, Gunanayagam K, Gelosa
G, Sharp DJ (2011) Inflammation after trauma: microglial activation
and traumatic brain injury. Ann Neurol 70:374 –383. CrossRef Medline
Ravichandran KS (2011) Beginnings of a good apoptotic meal: the find-me
and eat-me signaling pathways. Immunity 35:445– 455. CrossRef Medline
Reed-Geaghan EG, Savage JC, Hise AG, Landreth GE (2009) CD14 and toll-
like receptors 2 and 4 are required for fibrillar A-stimulated microglial
activation. J Neurosci 29:11982–11992. CrossRef Medline
Saatman KE, Duhaime AC, Bullock R, Maas AI, Valadka A, Manley GT
(2008) Classification of traumatic brain injury for targeted therapies.
J Neurotrauma 25:719 –738. CrossRef Medline
Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki
R, Ransohoff RM, Greenberg ME, Barres BA, Stevens B (2012) Micro-
glia sculpt postnatal neural circuits in an activity and complement-
dependent manner. Neuron 74:691–705. CrossRef Medline
Schmidt OI, Heyde CE, Ertel W, Stahel PF (2005) Closed head injury: an
inflammatory disease? Brain Res Brain Res Rev 48:388 –399. CrossRef
Medline
Sedgwick JD, Schwender S, Imrich H, Dörries R, Butcher GW, ter Meulen V
(1991) Isolation and direct characterization of resident microglial cells
from the normal and inflamed central nervous system. Proc Natl Acad Sci
U S A 88:7438 –7442. CrossRef Medline
Singleton RH, Zhu J, Stone JR, Povlishock JT (2002) Traumatically induced
axotomy adjacent to the soma does not result in acute neuronal death.
J Neurosci 22:791– 802. Medline
Soehnlein O, Lindbom L (2010) Phagocyte partnership during the onset
and resolution of inflammation. Nat Rev Immunol 10:427– 439. CrossRef
Medline
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